Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q92993
UPID:
KAT5_HUMAN
Alternative names:
60 kDa Tat-interactive protein; Histone acetyltransferase HTATIP; Lysine acetyltransferase 5; Protein 2-hydroxyisobutyryltransferase KAT5; Protein acetyltransferase KAT5; Protein crotonyltransferase KAT5; cPLA(2)-interacting protein
Alternative UPACC:
Q92993; B4E3C7; C9JL99; O95624; Q13430; Q17RW5; Q561W3; Q6GSE8; Q9BWK7
Background:
Histone acetyltransferase KAT5, also known as 60 kDa Tat-interactive protein, plays a pivotal role in transcriptional activation, DNA repair, and cell cycle regulation. It functions as a catalytic subunit of the NuA4 histone acetyltransferase complex, modifying nucleosomal histones H2A and H4, which is essential for transcriptional activation and DNA double-strand break repair. KAT5's acetylation of non-histone proteins further underscores its versatile role in cellular processes.
Therapeutic significance:
KAT5's involvement in neurodevelopmental disorders with dysmorphic facies, sleep disturbance, and brain abnormalities highlights its potential as a therapeutic target. Understanding KAT5's role could open doors to novel therapeutic strategies for treating these complex conditions.